CancerVax

A Universal Cancer Vaccine

Company Information

Website:

https://www.cancervax.com/

Sector:

Biotechnology

Location:

Lehi, UT

CancerVAX is a pre-clinical biotech company developing a universal cancer vaccine.

According to the World Health Organization, cancer is the second-leading cause of death globally. Cancer vaccines are one of the latest weapons designed to fight this disease. By 2030, the cancer-immunotherapy market is expected to reach $196 billion.

CancerVAX is developing a vaccine that will use the body’s own immune system to fight cancer. The company is headed by CEO Ryan Davies, who has co-founded multiple biotech companies. To aid in its development, CancerVAX is working with two research programs at the renowned cancer center at UCLA.

Team Background

Ryan Davies - Chief Executive Officer
Byron Elton - Chief Marketing Officer

Co-Investors

Raising
$1.23 million
Committed
$246.012K (20%)
Current Valuation
$81.54 million
Min. Investment
$525
Deal Type
Title III
(For all investors)
Offering Type
Equity
Finance History
  • $2 million
    2021-03-01
    Unknown
  • $833.264K
    2023-03-30
    Unknown
Notable Investors
Learn more on Start Engine